10x Genomics TXG recently entered into a multi-year research collaboration with the Cleveland Clinic to advance novel ...

Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Cleveland Clinic, a nonprofit ...

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...

Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, ...

Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader ...

As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company ...

10x Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now. On October 29, 2025, 10x Genomics announced the launch of its next-generation Chromium Flex assay, designed to help ...

Researchers uncover mechanisms behind divergent responses to immune checkpoint blockade between primary and metastatic brain tumors PLEASANTON, Calif., Sept. 5, 2023 /PRNewswire/ -- 10x Genomics (TXG) ...

SPT Labtech and 10x Genomics have partnered to provide automated workflows for single cell research. The collaboration will allow scientists to scale experiments on 10x’s Chromium Single Cell platform ...

10x Genomics TXG recently announced the acquisition of Proteintech Genomics, a division within Proteintech Group that ...

SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and 10x Genomics, Inc., a leader in single cell and spatial biology, today announced a ...